Cargando…

Clinical Impact and Cost-Effectiveness of Expanded Voluntary HIV Testing in India

BACKGROUND: Despite expanding access to antiretroviral therapy (ART), most of the estimated 2.3 to 2.5 million HIV-infected individuals in India remain undiagnosed. The questions of whom to test for HIV and at what frequency remain unclear. METHODS: We used a simulation model of HIV testing and trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venkatesh, Kartik K., Becker, Jessica E., Kumarasamy, Nagalingeswaran, Nakamura, Yoriko M., Mayer, Kenneth H., Losina, Elena, Swaminathan, Soumya, Flanigan, Timothy P., Walensky, Rochelle P., Freedberg, Kenneth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669338/ https://www.ncbi.nlm.nih.gov/pubmed/23741348 http://dx.doi.org/10.1371/journal.pone.0064604

Ejemplares similares

Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India
por: Freedberg, Kenneth A., et al.
Publicado: (2018)

Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India
por: Uhler, Lauren M., et al.
Publicado: (2010)

The Cost-Effectiveness of Tuberculosis Preventive Therapy for HIV-Infected Individuals in Southern India: A Trial-Based Analysis
por: Pho, Mai T., et al.
Publicado: (2012)

The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India
por: Zheng, Amy, et al.
Publicado: (2018)

2000. Rapid, Point-of-care Diagnosis of Tuberculosis with Novel Truenat Assay: Cost-Effectiveness and Budgetary Impact Analysis for India’s Public Sector
por: Lee, David J, et al.
Publicado: (2018)

Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India’s public sector
por: Lee, David J., et al.
Publicado: (2019)

Cost-Effectiveness of Genotype Testing for Primary Resistance in Brazil
por: Luz, Paula M., et al.
Publicado: (2015)

Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal
por: Losina, Elena, et al.
Publicado: (2009)

Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness
por: Bassett, Ingrid V., et al.
Publicado: (2014)

The Survival Benefits of Antiretroviral Therapy in South Africa
por: April, Michael D., et al.
Publicado: (2014)

Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions
por: Ciaranello, Andrea L, et al.
Publicado: (2011)

Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness
por: Yazdanpanah, Yazdan, et al.
Publicado: (2010)

Drug-Resistant Tuberculosis among HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa
por: Hom, Jeffrey K., et al.
Publicado: (2012)

Factors Associated with Self-Reported Repeat HIV Testing after a Negative Result in Durban, South Africa
por: Regan, Susan, et al.
Publicado: (2013)

Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed hiv-infected adults: a prospective, clinic-based study
por: Drain, Paul K, et al.
Publicado: (2014)

Using national laboratory data to assess cumulative frequency of linkage after transfer to community‐based HIV clinics in South Africa
por: Bassett, Ingrid V, et al.
Publicado: (2019)

The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis
por: Hyle, Emily P., et al.
Publicado: (2014)

The HIV cure research agenda: the role of mathematical modelling and cost-effectiveness analysis
por: Freedberg, Kenneth A, et al.
Publicado: (2015)

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017)

Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness
por: Yazdanpanah, Yazdan, et al.
Publicado: (2013)

Adolescent Linkage to Care After a Large-scale Transfer From a Hospital-based HIV Clinic to the Public Sector in South Africa
por: Ramirez-Avila, Lynn, et al.
Publicado: (2017)

Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

The cost‐effectiveness of HIV pre‐exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil
por: Luz, Paula M, et al.
Publicado: (2018)

Reliability, Validity, and Factor Structure of the Internalized AIDS-Related Stigma Scale in Southern India
por: Chan, Brian T., et al.
Publicado: (2019)

The Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa
por: Cloete, Christie, et al.
Publicado: (2014)

Association between internalized stigma and depression among HIV-positive persons entering into care in Southern India
por: Chan, Brian T, et al.
Publicado: (2017)

Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts
por: Neilan, Anne M., et al.
Publicado: (2020)

Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts
por: Neilan, Anne M, et al.
Publicado: (2020)

Risk Factors for Late-Stage HIV Disease Presentation at Initial HIV Diagnosis in Durban, South Africa
por: Drain, Paul K., et al.
Publicado: (2013)

Development, Calibration and Performance of an HIV Transmission Model Incorporating Natural History and Behavioral Patterns: Application in South Africa
por: McCormick, Alethea W., et al.
Publicado: (2014)

The Convergence of Disclosure Concerns and Poverty Contributes to Loss to HIV Care in India: A Qualitative Study
por: Perlo, Jared, et al.
Publicado: (2020)

The “ART” of Linkage: Pre-Treatment Loss to Care after HIV Diagnosis at Two PEPFAR Sites in Durban, South Africa
por: Losina, Elena, et al.
Publicado: (2010)

Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa
por: Bassett, Ingrid V., et al.
Publicado: (2017)

Survival benefits of antiretroviral therapy in Brazil: a model-based analysis
por: Luz, Paula M, et al.
Publicado: (2016)

Gender differences in oral lesions among persons with HIV disease in Southern India
por: Rao, Umadevi Krishna Mohan, et al.
Publicado: (2012)

Cost-effectiveness of World Health Organization 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe
por: Ciaranello, Andrea L., et al.
Publicado: (2013)

A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial
por: Bassett, Ingrid V, et al.
Publicado: (2013)

HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?
por: Sax, Paul E., et al.
Publicado: (2014)

The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis
por: Dunning, Lorna, et al.
Publicado: (2017)

Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa
por: Dugdale, Caitlin M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_st5a1n0lsiparkog7mkrfoglf0